Attention-deficit/hyperactivity disorder in elite athletes: a narrative review.

athletes attention-deficit/hyperactivity disorder non-stimulants psychosocial treatment stimulants

Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Jun 2019
Historique:
accepted: 08 04 2019
pubmed: 18 5 2019
medline: 2 7 2019
entrez: 18 5 2019
Statut: ppublish

Résumé

Attention-deficit/hyperactivity disorder (ADHD) is a common brain developmental disorder in the general population that may be even more prevalent in elite athletes in certain sports. General population studies of ADHD are extensive and have reported on prevalence, symptoms, therapeutic and adverse effects of treatment and new clinical and research findings. However, few studies have reported on prevalence, symptoms and treatments of ADHD in elite athletes. This narrative review summarises the literature on symptoms, comorbidities, effects of ADHD on performance and management options for elite athletes with ADHD. The prevalence of ADHD in student athletes and elite athletes may be 7%-8%. The symptoms and characteristics of ADHD play a role in athletes' choice of a sport career and further achieving elite status. Proper management of ADHD in elite athletes is important for safety and performance, and options include pharmacologic and psychosocial treatments.

Identifiants

pubmed: 31097459
pii: bjsports-2019-100713
doi: 10.1136/bjsports-2019-100713
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

741-745

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Doug Hyun Han (DH)

Department of Psychiatry, Chung Ang University Hospital, Seoul, Republic of Korea hduk70@gmail.com.

David McDuff (D)

Psychiatry, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
MD Sports Performance, Ellicott City, Maryland, USA.

Donald Thompson (D)

School of Medicine, University of Maryland, Baltimore, Maryland, USA.

Mary E Hitchcock (ME)

University of Wisconsin-Madison, Ebling Library for the Health Sciences, Madison, WI, USA.

Claudia L Reardon (CL)

Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisconsin, USA.

Brian Hainline (B)

National Collegiate Athletic Association (NCAA), Indianapolis, Indiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH